The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.

Hyle EP, Bekker LG, McCluskey SM, Chen W, Sax PE, Moosa MY, Machoko M, Bangs A, Steegen K, Siedner MJ, van de Vijver DAMC, Resch SC, Neilan AM, Phillips A, Walensky RP, Lessells RJ, Weinstein MC, Dugdale CM, Wood R, Freedberg KA

Open source

DOI: 10.1016/s2352-3018(25)00164-x
Published: 2025 Sep
Container: The lancet. HIV
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3018-25-00164-x,
  title = {The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.},
  author = {Hyle EP and Bekker LG and McCluskey SM and Chen W and Sax PE and Moosa MY and Machoko M and Bangs A and Steegen K and Siedner MJ and van de Vijver DAMC and Resch SC and Neilan AM and Phillips A and Walensky RP and Lessells RJ and Weinstein MC and Dugdale CM and Wood R and Freedberg KA},
  year = {2025},
  journal = {The lancet. HIV},
  doi = {10.1016/s2352-3018(25)00164-x},
  url = {https://doi.org/10.1016/s2352-3018(25)00164-x}
}

RIS

TY  - JOUR
TI  - The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.
AU  - Hyle EP
AU  - Bekker LG
AU  - McCluskey SM
AU  - Chen W
AU  - Sax PE
AU  - Moosa MY
AU  - Machoko M
AU  - Bangs A
AU  - Steegen K
AU  - Siedner MJ
AU  - van de Vijver DAMC
AU  - Resch SC
AU  - Neilan AM
AU  - Phillips A
AU  - Walensky RP
AU  - Lessells RJ
AU  - Weinstein MC
AU  - Dugdale CM
AU  - Wood R
AU  - Freedberg KA
PY  - 2025
JO  - The lancet. HIV
DO  - 10.1016/s2352-3018(25)00164-x
UR  - https://doi.org/10.1016/s2352-3018(25)00164-x
ER  -

APA

EP, H., LG, B., SM, M., W, C., PE, S., MY, M., M, M., A, B., K, S., MJ, S., DAMC, V. D. V., SC, R., AM, N., A, P., RP, W., RJ, L., MC, W., CM, D., R, W., & KA, F. (2025). The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.. The lancet. HIV. https://doi.org/10.1016/s2352-3018(25)00164-x

Source records

pubmed · retrieved 2026-09-27T12:00:33.122Z